Therapeutic agents for respiratory diseases
AssigneeMedion Research Laboratories
InventorsMasaya Tanaka, Masato Hiki
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedion Research Laboratories
InventorsMasaya Tanaka, Masato Hiki
Estimating the term…
Prophylactic or therapeutic agents for respiratory diseases, allergic diseases, keratosis, and carcinomatous pain, containing Smilax china or a plant analogous thereto as the active ingredient. These agents can improve the condition and predisposition of acute and chronic respiratory diseases, such as acute bronchitis, bronchial asthma, asthmatic bronchitis, chronic bronchitis, pan bronchiolitis and bronchiectasis, allergic diseases, such as atopic dermatitis, pollinosis, allergic rhinitis and allergic conjunctivitis, and keratosis, such as psoriasis, lichen, ichthyosis, furfur, and palmoplantar keratosis without side effects and at the same time can lower serum IgE level on an abnormally high level in a short period of time. After the symptom and predisposition have been improved, these agents can, even after suspension of administration, persistently lower the serum IgE level and in addition can inhibit the recurrence of the symptom.
A method of preventing or treating a respiratory disease, wherein the respiratory disease is bronchial asthma or asthamatic bronchitis, which comprises administering a therapeutically effective amount Smilax china, or an extract thereof, to a patient in need thereof.
A method of preventing or treating an allergic disease selected from the group consisting of atopic dermatitis, pollinosis, allergic rhinitis, and allergic conjunctivitis, said method comprising:
A method of preventing or treating carcinomatous pain which comprises administering an effective amount of a member of the genus Smilax, or an extract thereof, to a patient with carcinomatous pain.
Dependencies are inferred from the claim text.